Climagest 1mg Tablets
S280-281 LEAFLET Climagest 20141216
Some effects could be serious
These symptoms need immediate medical attention:
• Unexpected vaginal bleeding or spotting (breakthrough bleeding) after taking Climagest for some time, or after you stop treatment
• Painful menstrual periods
• Painful swelling and redness of the legs
• Sudden chest pain
• Difficulty in breathing
• Pain in your chest that spreads to your arm or neck
• Yellowing of the eyes and face (jaundice)
• Rapid increase in your blood pressure
• Unexplained migraine-like headaches
• Breast changes, including dimpling of the breast skin, changes in the nipple, lumps that you can see or feel.
Stop taking Climagest and tell your doctor immediately if you get any of the effects mentioned above. Check the risks to be aware of with HRT in general in section 2, When to take special care with Climagest.
Other side effects
In addition, the following side effects have been reported with Climagest:
• Breast tension and pain, breast cancer.
• Discharge from the vagina.
• Headache, dizziness, vertigo, changes in sexual desire, depression.
• Increased blood pressure, palpitations (sensation of fluttering in the chest), tender or painful veins (signs of thrombophlebitis), fluid retention, nose bleeds.
• Indigestion, wind, nausea, vomiting, abdominal pain and bloating, problems with your gall bladder (biliary stasis).
• General itching, hair loss, hives and skin rash.
• Glucose intolerance which can make you sweat or feel faint after eating.
• Weight gain.
• Fibroids (benign growth in the uterus).
• Pain in extremity.
The following side effects have been reported with other HRTs:
• gallbladder disease,
• various skin disorders:
- discoloration of the skin specially of face or neck known as “pregnancy patches” (chloasma)
- painful reddish skin nodules (erythema nodosum)
- rash with target-shaped reddening or sores (erythema multiforme)
• decline in memory or mental ability
• diarrhoea
• dry eyes and contact lens discomfort Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store Climagest
• KEEP OUT OF THE SIGHT AND REACH OF CHILDREN.
• Do not use Climagest after the expiry date which is stated on the carton and blister strip. The expiry date refers to the last day of that month.
• Do not store your tablets above 25°C.
• Store in the original package.
• Do not refrigerate.
• Protect from light and moisture.
• If the medicine becomes discoloured or shows any other signs of deterioration, you should seek the advice of your pharmacist who will tell you what to do.
• Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
6. Contents of the pack and other information
What Climagest contains
• Each Climagest 1mg Tablets contains sixteen round, grey-blue film-coated tablets containing 1mg of the active ingredient estradiol valerate and twelve round, white film-coated tablets containing 1mg of the active ingredient estradiol valerate and 1mg of the active ingredient norethisterone.
• Each Climagest 2mg Tablets contains sixteen round, blue, film-coated tablets containing 2mg of the active ingredient estradiol valerate and twelve round, pale yellow, film-coated tablets containing 2mg of the active ingredient estradiol valerate and 1mg of the active ingredient norethisterone.
• The other ingredients of the 1 mg grey-blue tablets are: lactose monohydrate, maize starch, povidone (K-30), talc, magnesium stearate, propylene glycol, hypromellose, indigo carmine aluminium lake (E132), disodium edetate, titanium dioxide.
The other ingredients of the 1mg white tablets are: lactose monohydrate, maize starch, povidone (K-30), talc, magnesium stearate, propylene glycol, hypromellose, titanium dioxide.
• The other ingredients of the 2mg blue tablets are: lactose monohydrate, maize starch, povidone (K-30), talc, magnesium stearate, propylene glycol, hypromellose, indigo carmine aluminium lake (E132), titanium dioxide.
The other ingredients of the 2mg pale yellow tablets are: lactose monohydrate, maize starch, povidone (K-30), talc, magnesium stearate, propylene glycol, hypromellose, titanium dioxide, yellow iron oxide (E172).
What Climagest looks like and contents of the pack
Climagest 1mg tablets contain 16, round, grey-blue film-coated tablets and 12, round, white film-coated tablets. The grey-blue tablets are marked 'OC on one side and ‘CG’ on the other. The white tablets are marked ‘OE’ on one side and ‘CG’ on the other.
Climagest 2mg tablets contain 16, round, blue, film-coated tablets and 12, round, pale yellow, film-coated tablets. The blue tablets are marked ’OD’ on one side and ‘CG’ on the other. The pale yellow tablets are marked ‘OF’ on one side and ‘CG’ on the other.
Climagest Tablets are available as blister packs of 84 (3 x 28) tablets.
Product Licence holder
Procured from within the EU and repackaged by the Product Licence holder: S&M Medical Ltd, Chemilines House, Alperton Lane, Wembley, HAO 1DX.
Manufacturer
This product is manufactured by Novartis Pharma GmbH, 90327 Nuremberg Germany.
|POM| PL No. 19488/0280 Climagest 1mg Tablets PL No. 19488/0281 Climagest 2mg Tablets
Leaflet revision date: 16 December 2014
Climagest is a registered trade mark of Novartis AG, Switzerland.
S280-281 LEAFLET Climagest 20141216
S280-281 LEAFLET Climagest 20141216
PACKAGE LEAFLET: INFORMATION FOR THE USER CLIMAGEST 1mg TABLETS CLIMAGEST 2mg TABLETS (estradiol valerate/norethisterone)
Your medicine is known by any of the above names but will be referred to as Climagest throughout the following patient information leaflet.
Read all of this leaflet carefully, before you start taking this medicine because it contains important information for you.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
What is in this leaflet:
1. What Climagest is and what it is used for
2. What you need to know before you take Climagest
3. How to take Climagest
4. Possible side effects
5. How to store Climagest
6. Content of the pack and other information
1 What Climagest is and what it is used for
Climagest is a Hormone Replacement Therapy (HRT). It contains two types of female hormones, an oestrogen and a progestogen. Climagest is used in postmenopausal women with at least 6 months since their last natural period. Oestradiol valerate is identical to the natural female hormone oestrogen. This hormone is produced by the ovaries before the menopause. Norethisterone belongs to the group of hormones known as progestogens. It has effects similar to the natural female hormone progesterone, also produced by the ovaries before the menopause.
Climagest is used for:
Relief of symptoms occurring after menopause
Menopause occurs naturally in all women, usually between the ages of 45 and 55 years. It occurs also in younger women who have their ovaries removed by surgery. During the menopause, the amount of the oestrogen produced by a woman’s body drops. This can cause unpleasant symptoms such as hot face, neck and chest (hot flushes), sleep problems, irritability and depression. Some women also have problems with urine control or dryness of the vagina, which may cause discomfort during or after sexual intercourse.
Climagest alleviates these symptoms after menopause. You will only be prescribed
Climagest if your symptoms seriously hinder your daily life.
If oestrogen is taken on its own, there is a greater risk of abnormal growth of the womb lining (endometrial hyperplasia) and endometrial cancer. The norethisterone in the white Climagest tablet reduces these risks in women who still have their womb.
2 What you need to know before you take Climagest
Medical history and regular check-ups
The use of HRT carries risks which need to be considered when deciding whether to start taking it, or whether to carry on taking it.
The experience in treating women with a premature menopause (due to ovarian failure or surgery) is limited. If you have a premature menopause the risks of using
HRT may be different. Please talk to your doctor.
Before you start (or restart) Climagest, your doctor will ask you about your own and your family’s medical history. Your doctor may decide to perform a physical examination. This may include an examination of your breasts and/or an internal examination, if necessary. He/she should tell you what kind of changes in the breast you should look out for and may advise you to have a breast X-ray (a mammogram).
Once you have started on Climagest you should see your doctor for regular check-ups (at least once a year). At these check-ups, discuss with your doctor the benefits and risks of continuing with Climagest.
Go for regular breast screening, as recommended by your doctor. Do not take Climagest
if any of the following applies to you. If you are not sure about any of the points below, talk to your doctor before taking Climagest,
• if you have or have ever had breast cancer, or if you are suspected of having it;
• if you have cancer which is sensitive to oestrogens, such as cancer of the womb lining (endometrium), or if you are suspected of having it;
• if you have any unexplained vaginal bleeding;
• if you have excessive thickening of the womb lining
(endometrial hyperplasia) that is not being treated;
• if you have severe kidney disease;
• if you have or have ever had a blood clot in a vein (thrombosis), such as in the legs (deep venous thrombosis) or the lungs (pulmonary embolism)',
• if you have a blood clotting disorder (such as protein C, protein S, or antithrombin deficiency);
• if you have or recently have had a disease caused by blood clots in the arteries, such as a heart attack, stroke or angina;
• if you have or have ever had a liver disease and your liver function tests have not returned to normal;
• if you have a rare blood problem called “porphyria” which is passed down in families (inherited);
• if you are allergic (hypersensitive) to oestradiol valerate or norethisterone or any of the other ingredients of Climagest (listed in section 6);
• if you are pregnant, or think you might be.
If any of the above conditions appear for the first time while taking Climagest, stop taking it at once and consult your doctor immediately.
When to take special care with Climagest
Tell your doctor if you have ever had any of the following problems, before you start the treatment, as these may return or become worse during treatment with Climagest. If so, you should see your doctor more often for check-ups.
• Fibroids inside your womb
• Growth of womb lining outside your womb (endometriosis)
or a history of excessive growth of the womb lining (endometrial hyperplasia)
• Increased risk of developing blood clots (see “Blood clots in a vein (thrombosis)”)
• Increased risk of getting an oestrogen-sensitive cancer (such as having a mother, sister or daughter or grandmother who has had breast cancer),
• High blood pressure
• A liver disorder, such as a benign liver tumour (liver adenoma)
• Diabetes
• Gallstones
• Migraine or severe headaches
• A disease of the immune system that affects many organs of the body (Systemic lupus erythematosus, SLE)
• Epilepsy
• Asthma
• A disease affecting the eardrum and hearing (otosclerosis)
• A very high level of fat in your blood (triglycerides)
• Fluid retention due to cardiac or kidney problems
• Hypothyroidism (a condition in which your thyroid gland fails to produce enough thyroid hormone and for which you are treated with thyroid hormone replacement therapy)
• Hereditary angioedema or episodes of rapid swelling of the hands, feet, face, lips, eyes, tongue, throat (airway blockage) or digestive tract.
Stop taking Climagest and see a doctor immediately.
If you notice any of the following when taking HRT:
- Any of the conditions mentioned in the ‘Do Not take Climagest’ section
- Yellowing of your skin or the whites of your eyes (jaundice). These may be signs of a liver disease
- A large rise in your blood pressure (symptoms may be headache, tiredness, dizziness)
- Migraine-like headaches which happen for the first time, with or without disturbed vision. Headaches like these can be an early sign of a stroke. If you have already had a stroke, talk with your doctor about whether the benefits of the treatment outweigh the possibly increased risk.
- If you get pain in your chest that spreads to your arm or neck. This pain may be a sign of heart disease.
- If you become pregnant
- If you notice signs of a blood clot, such as:
• painful swelling and redness of the legs
• sudden chest pain
• difficulty in breathing
For more information, see ‘Blood clots in a vein (thrombosis)’
Note: Climagest is not a contraceptive. If it is less than 12 months since your last menstrual period or you are under 50 years old, you may still need to use additional contraception to prevent pregnancy. Speak to your doctor for advice.
HRT and cancer
Excessive thickening of the lining of the womb (endometrial hyperplasia) and cancer of the lining of the womb (endometrial cancer)
Taking oestrogen-only HRT will increase the risk of excessive thickening of the lining of the womb (endometrial hyperplasia) and cancer of the womb lining (endometrial cancer).
The progestogen in Climagest protects you from this extra risk.
In women who still have a womb and who are not taking HRT, on average, 5 in 1000 will be diagnosed with endometrial cancer between the ages of 50 and 65.
For women aged 50 to 65 who still have a womb and who take oestrogen-only HRT, between 10 and 60 women in 1000 will be diagnosed with endometrial cancer (i.e. between 5 and 55 extra cases), depending on the dose and for how long it is taken.
Irregular bleeding
You may have irregular bleeding or drops of blood (spotting) during the first 3-6 months of taking Climagest. However, if the irregular bleeding:
- carries on for more than the first 6 months
- starts after you have been taking Climagest for more than 6 months
- carries on after you have stopped taking Climagest
- if you have painful menstrual periods
See your doctor as soon as possible.
Breast cancer
Evidence suggests that taking combined oestrogen-progestogen and possibly also oestrogen-only HRT increases the risk of breast cancer. The extra risk depends on how long you take HRT. The additional risk becomes clear within a few years.
However, it returns to normal within a few years (at most 5) after stopping treatment.
Compare
Women aged 50 to 79 who are not taking HRT, on average, 9 to 17 in 1000 will be diagnosed with breast cancer over a 5-year period. For women aged 50 to 79 who are taking oestrogen-progestogen HRT over 5 years, there will be 13 to 23 cases in 1000 users (i.e. an extra 4 to 6 cases).
Regularly check your breasts. See your doctor if you notice any changes such as:
• dimpling of the skin
• change in the nipple
• any lump you can see or feel Ovarian cancer
Ovarian cancer is rare. A slightly increased risk of ovarian cancer has been reported in women taking HRT for at least 5 to 10 years.
Women aged 50 to 69 who are not taking HRT, on average about 2 women in 1000 will be diagnosed with ovarian cancer over a 5-year period. For women who have been taking HRT for 5 years, there will be between 2 and 3 cases per 1000 users (i.e. up to 1 extra case).
Effect of HRT on heart and circulation Blood clots in a vein (thrombosis)
The risk of blood clots in the veins is about 1.3 to 3- times higher in HRT users than in non-users, especially during the first year of taking it.
Blood clots can be serious, and if one travels to the lungs, it can cause chest pain, breathlessness, fainting or even death.
You are more likely to get a blood clot in your veins as you get older and if any of the following applies to you. Inform your doctor if any of these situations applies to you:
• you are unable to walk for a long time because of major surgery, injury or illness (see also section 3, If you need to have surgery)
• you are seriously overweight (BMI >30 kg/m2)
• you have any blood clotting problem that needs long-term treatment with a medicine used to prevent blood clots
• if any of your close relatives has ever had a blood clot in the leg, lung or another organ
• you have systemic lupus erythematosus (SLE)
• you have cancer.
For signs of a blood clot, see “Stop taking Climagest and see a doctor immediately”.
Compare
Looking at women in their 50s who are not taking HRT, on average, over a 5-year period, 4 to 7 in 1000 would be expected to get a blood dot in a vein.
For women in their 50s who have been taking oestrogen-progestogen HRT for over 5 years, there will be 9 to 12 cases in 1000 users (i.e. an extra 5 cases).
Heart disease (heart attack)
There is no evidence that HRT will prevent a heart attack.
Women over the age of 60 years who use oestrogen-progestogen HRT are slightly more likely to develop heart disease than those not taking any HRT.
Stroke
The risk of getting stroke is about 1.5 times higher in HRT users than in non-users.
The number of extra cases of stroke due to use of HRT will increase with age.
Compare
Looking at women in their 50s who are not taking HRT, on average, 8 in 1000 would be expected to have a stroke over a 5-year period. For women in their 50s who are taking
HRT, there will be 11 cases in 1000 users, over 5 years (i.e. an extra 3 cases).
Other conditions
HRT will not prevent memory loss. There is some evidence of a higher risk of memory loss in women who start using HRT after the age of 65. Speak to your doctor for advice.
Taking other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription, herbal medicines or other natural products. Some medicines may interfere with the effect of Climagest. This might lead to irregular bleeding. This applies to the following medicines:
• medicines for epilepsy (such as phenobarbital, phenytoin, carbamazepine),
• medicines for tuberculosis (such as rifampicin, rifabutin),
• medicines for HIV infection (such as nevirapine, efavirenz, ritonavir, telaprevir, nelfinavir),
• herbal remedies containing St John’s wort (Hypericum perforatum).
Laboratory tests
If you need a blood test, tell your doctor or the laboratory staff that you are taking Climagest, because this medicine can affect the results of some tests.
Pregnancy and breast-feeding
Climagest is for use in postmenopausal women only. If you become pregnant, stop taking Climagest and contact your doctor. Do not take Climagest if you are pregnant or while you are breast-feeding.
Driving and using machines
Climagest has no known effects on the ability to drive and use machines.
Climagest contains lactose
Lactose is a form of sugar. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking Climagest.
3 How to take Climagest
Always use this medicine exactly as your doctor has told you. Your doctor will aim to prescribe the lowest dose to treat your symptom for as short as necessary.
Speak to your doctor if you think this dose is too strong or not strong enough.
During the treatment your doctor may adjust the dose according to your individual needs.
When to start treatment
Climagest is a continuous sequential HRT. This means that oestrogen is given continuously, and progestogen is added for 12 days of the cycle.
• If you are not currently taking HRT and still having periods, it is advisable to take the first tablet on the first day of your period (first day of the bleed) unless your doctor tells you otherwise. If your periods are infrequent, or have stopped, your doctor may suggest that you start immediately.
• If you are changing from a sequential HRT or cyclic HRT,
you should complete your treatment cycle and then start taking Climagest immediately.
• If you are changing from a continuous combined HRT and
your periods have stopped, you can start taking Climagest at any time. If you still have periods, start taking Climagest on the first day of your period.
How to take Climagest
Take one tablet each day by following the sequence of numbers and arrows on the calendar pack.
Swallow your tablets whole with a glass of water.
The pack has been designed specifically to help you take the tablets correctly.
Write the name of the day you take your first tablet in the box below. For example, if you start your tablets on a Wednesday, then write “Wednesday” in the box. This day will also be the day on which you will take tablets 8,15 and 22. This will help you check that you have taken each tablet on the right day.
Write your start day here:
When you finish one blister pack, start the new one the next day whether or not you experience bleeding. This will normally be the same day of the week as you started the previous blister pack. Do not take a break between blister packs unless your doctor tells you.
The tablets are best taken at the same time every day; try to get into a routine.
Follow your doctor’s instructions as to how and when you should take Climagest tablets and never change the dose yourself, however well you feel.
If you are unsure about how much medicine to take or when to take it, ask your doctor or pharmacist.
How long to take Climagest
From time to time, you will need to discuss with your doctor the possible risks and benefits associated with Climagest and whether you still need the treatment. It is important that you take the lowest possible effective dose and only for as long as needed.
If you have taken more Climagest than you should
Contact your doctor or pharmacist immediately if you have taken too much Climagest.
If you forget to take Climagest
If you forget to take a tablet at your usual time, try to take it within 12 hours. If this is not possible, leave the forgotten tablet and continue to take the remaining tablets at the usual time.
If you need to have surgery
If you are going to have surgery, tell the surgeon that you are taking Climagest. You may need to stop taking Climagest about 4 to 6 weeks before the operation to reduce the risk of a blood clot (see section 2, Blood clots in a vein). Ask your doctor when you can start taking Climagest again.
If you stop taking Climagest
Stopping Climagest may increase the risk of breakthrough bleeding or spotting. If this occurs after you stop treatment, contact your doctor immediately. Your doctor will need to work out the reasons for this.
After a long treatment break, consult your doctor before starting to take Climagest again.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
4 Possible side effects
The following diseases are reported more often in women using FIRT compared to women not using HRT:
• breast cancer
• abnormal growth or cancer of the lining of the womb (endometrial hyperplasia or cancer)
• ovarian cancer
• blood clots in the veins of the legs or lungs (venous thromboembolism)
• heart disease
• stroke
• probable memory loss if HRT is started over the age of 65 For more information about these side effects, see Section 2.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
S280-281 LEAFLET Climagest 20141216